This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Heart Failure

Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform

Sponsored by Intermountain Health Care, Inc.

About this trial

Last updated 7 years ago

Study ID

1050557

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 7 years ago

What is this trial about?

The purpose of this study is to create a smartphone app that delivers the educational content of the current Intermountain MAWDS* program and allows patients to enter and track their MAWDS data within the app; and to determine if a broad-scale project can be conducted within the limits of currently available technology. Information from this study will be used to design a larger study that is powered to assess the association between data obtained via a MAWDS app and heart failure outcomes. (*MAWDS- Medications, Activity, Weight, Diet, Symptoms)

What are the participation requirements?

Yes

Inclusion Criteria

1. Male or female > 18 years of age

2. Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures

3. Documentation of heart failure of any etiology, using standard of care criteria for diagnosis, and based on clinical assessment of the Principal Investigator and/or his delegate

4. Possess (and are comfortable using) an iPhone of appropriate age (model 5S or newer, since these models have a motion coprocessor that can run iOS 8 or later, as needed to run the app)

5. Willing and able to comply with the instructions for entering their MAWDS data into the app installed in their iPhones

No

Exclusion Criteria

1. Significant and/or severe co-morbidities, as assessed by the Principal Investigator and/or his delegate

2. Currently in hospice care or planned discharge to hospice care at home or to a hospice care facility

3. Inability to read and/or understand English (Non-English speaking and reading participants will be excluded since the program requires a variety of communications, not all of which have been validated in a language other than English).

4. Other conditions that in the opinion of the Principal Investigator and/or Sub-Investigator may increase risk to the subject and/or compromise the quality of the clinical trial

5. The Study Clinician(s) determine(s) that the subject is not eligible for participation in this research study